Inventor · disambiguated record
Yogita Krishnamachari
Also filed as: KRISHNAMACHARI YOGITA
6 granted patents·7 pending applications·18 citations·filing 2009–2023
79Inventor score
Files withMERCK SHARP & DOHME LLC5ARRAY BIOPHARMA INC3FORREST JR WILLIAM P1LALA MALLIKA1MERCK SHARP & DOHME1
Top patents by PatentIndex Score
13 records- 0188US11633476B2Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2018·Granted Apr 25, 2023·6 cites·21 claims
- 0286US9763941B2Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateARRAY BIOPHARMA INC·Filed 2016·Granted Sep 19, 2017·6 cites·22 claims
- 0382US10258622B2Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamateARRAY BIOPHARMA INC·Filed 2017·Granted Apr 16, 2019·3 cites·22 claims
- 0479US2023263887A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0579US2023321234A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0671US12319735B2Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodiesMERCK SHARP & DOHME LLC·Filed 2019·Granted Jun 3, 2025·1 cites·71 claims
- 0770US9572894B2Biodegradable particulate formulationsSALEM ALIASGER K·Filed 2011·Granted Feb 21, 2017·2 cites·5 claims
- 0862US10561654B2Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateARRAY BIOPHARMA INC·Filed 2018·Granted Feb 18, 2020·0 cites·14 claims
- 0957US2022089738A1Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use ThereofMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 1056US2023365692A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and hyaluronidase variants and fragments thereof and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 1151US2010190257A1Self-Assembly of a Cell-Microparticle HybridUNIV IOWA RES FOUND·Filed 2009·Application pending·0 cites
- 1250US2025074983A1Methods for treating cancer with subcutaneous administration of anti-pd1 antibodiesLALA MALLIKA·Filed 2022·Application pending·0 cites
- 1348US2021380694A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofFORREST JR WILLIAM P·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yogita Krishnamachari files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →